References
- Abbassian A., Wallace D. M. Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder. J Urol 1966; 96: 461–465
- Bergkvist A., Ljungqvist A., Moberger G. Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 1965; 130: 371–378
- Cole D. R., Howley T., Rowan R., Dreyer B., Tan Y. L., Gonzalez E., Rousselot L. M. Absorption and activity studies on intraluminal Thio-TEPA in the dog's bladder. J Urol 1965; 94: 556–558
- Drew J. E., Marshall V. F. The effects of topical Thiotepa on the recurrence rate of superficial bladder cancers. J Urol 1968; 99: 740–743
- Edgren B., Forsgren L., Boström H. Grav benmärgsskada efter blåsinstallationer med tiotepa. Nord Med 1966; 75: 481
- Esquivel E. L., Jr, Mackenzie A. R., Whitmore W. F., Jr. Treatment of bladder tumors by instillation of thio-TEPA, actinomycin D, or 5-fluorouracil. Invest Urol 1965; 2: 381–386
- Furnari S., Pavone-Macaluso M., Lattuca C., Leone G. Tio-Tepa endovescicale nel trattarnento delle neoplasie papillari della vescica. Arch Ital Urol 1968; 41: 187–198
- Oravisto K. J. Topical use of Thio-Tepa for tumours of the bladder. Urol Int 1965; 20: 23–28
- Prout G. K., Jr., Bross I. D. J., Slack N. H., Ausman R. K. Carcinoma of the bladder, 5-fluorouracil and the critical rôle of a placebo. Cancer 1968; 22: 926–931
- Veenema K. J., Dean A. L., Jr., Uson A. C., Roberts M., Longo F. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. J Urol 1969; 101: 711–715
- Wescott J. W. The prophylactic use of Thio-Tepa in transitional cell carcinoma of the bladder. J Urol 1966; 96: 913–918